| Value | Category | Cases | |
|---|---|---|---|
| 1 | Oral PrEP only | 171 |
75.3%
|
| 2 | 2 monthly Injectable (im) cabotegravir only | 55 |
24.2%
|
| 3 | DapiRing Only | 0 |
0%
|
| 4 | 6 monthly subcutaneous lenocapovir | 1 |
0.4%
|
| 5 | Oral PrEP and Injectable cabotegravir | 0 |
0%
|
| 96 | Other | 0 |
0%
|
| Sysmiss | 6803 |